Search Results - "van Veldhuisen, Eran"

Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy by van Veldhuisen, Eran, Vogel, Jantien A., Klompmaker, Sjors, Busch, Olivier R., van Laarhoven, Hanneke W.M., van Lienden, Krijn P., Wilmink, Johanna W., Marsman, Hendrik A., Besselink, Marc G.

“…Determining the resectability of locally advanced pancreatic cancer (LAPC) after induction chemotherapy is complex since CT-imaging cannot accurately portray…”
Get full text

Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies by van Veldhuisen, Eran, van den Oord, Claudia, Brada, Lilly J, Walma, Marieke S, Vogel, Jantien A, Wilmink, Johanna W, Del Chiaro, Marco, van Lienden, Krijn P, Meijerink, Martijn R, van Tienhoven, Geertjan, Hackert, Thilo, Wolfgang, Christopher L, van Santvoort, Hjalmar, Groot Koerkamp, Bas, Busch, Olivier R, Molenaar, I Quintus, van Eijck, Casper H, Besselink, Marc G

“…Locally advanced pancreatic cancer (LAPC) has several definitions but essentially is a nonmetastasized pancreatic cancer, in which upfront resection is…”
Get full text

Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review by Agnass, Pierre, van Veldhuisen, Eran, van Gemert, Martin J. C., van der Geld, Cees W. M., van Lienden, Krijn P., van Gulik, Thomas M., Meijerink, Martijn R., Besselink, Marc G., Kok, H. Petra, Crezee, Johannes

“…Irreversible electroporation (IRE) is a relatively new ablation method for the treatment of unresectable cancers. Although the main mechanism of IRE is…”
Get full text

Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study by Vogel, Jantien A., van Veldhuisen, Eran, Alles, Lindy K., Busch, Olivier R., Dijk, Frederike, van Gulik, Thomas M., Huijzer, Goos M., Besselink, Marc G., van Lienden, Krijn P., Verheij, Joanne

“…Irreversible electroporation causes cell death through low frequency, high voltage electrical pulses and is increasingly used to treat non-resectable cancers…”
Get full text

HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings by Agnass, Pierre, Rodermond, Hans M., Zweije, Remko, Sijbrands, Jan, Vogel, Jantien A., van Lienden, Krijn P., van Gulik, Thomas M., van Veldhuisen, Eran, Franken, Nicolaas A. P., Oei, Arlene L., Kok, H. Petra, Besselink, Marc G., Crezee, Johannes

“…Electric permeabilization of cell membranes is the main mechanism of irreversible electroporation (IRE), an ablation technique for treatment of unresectable…”
Get full text

CA19-9 response combined with CT-imaging accurately predicts resectability of locally advanced pancreatic carcinoma following neoadjuvant chemotherapy by van Veldhuisen, Eran, Vogel, Jantien, Busch, Olivier, van Lienden, Krijn, Wilmink, Hanneke, Marsman, Hendrik, Besselink, Marc

“…[...]patients can be considered unresectable if treatment response is underestimated. [...]prognostics of resectability in LAPC patients undergoing…”
Get full text

Surgical and oncological outcomes after neoadjuvant FOLFIRINOX chemotherapy for (borderline) resectable and locally advanced pancreatic cancer: a pan-European cohort by van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P., Hilal, Mohammad Abu, Bassi, Claudio, Busch, Olivier R., Chiaro, Marco del, Wilmink, Johanna W., Molenaar, I. Quintus, Lesurtel, Mickael, Keck, Tobias, Kleeff, Jörg, Salvia, Roberto, Strobel, Oliver, Koerkamp, Bas Groot, Besselink, Marc G.

Get full text

Radiofrequency ablation and irreversible electroporation in locally advanced pancreatic cancer: Competitive or complementary treatment modalities? by Walma, Marieke S., Vogel, Jantien A., van Veldhuisen, Eran, Busch, Olivier R., Wilmink, J.W., van Santvoort, Hjalmar C., Besselink, Marc G., Molenaar, I.Q., van Lienden, Krijn P.

Get full text

Added value of CA19-9 response to recist staging in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy by van Veldhuisen, Eran, Vogel, Jantien A., Busch, Olivier R.C., van Laarhoven, Hanneke W.M., van Lienden, Krijn P., Wilmink, Johanna W., Marsman, Hendrik A., Besselink, Marc G.

“…Introduction: Determining the resectability of locally advanced pancreatic cancer (LAPC) is difficult as computed tomography RECIST-assessment often…”
Get full text

Intra-operative ultrasound to determine resectability during surgical exploration of primary non-resectable pancreatic cancer following induction chemotherapy by Walma, Marieke S., van Veldhuisen, Eran, van Rijssen, L.B., Busch, Olivier R., Bruijnen, Rutger C., van Delden, Otto M., Mohammad, Nadia Haj, de Hingh, Ignace, Yo, Lonneke S., van Laarhoven, Hanneke W., van Leeuwen, Maarten S., Nio, C.Y., van Santvoort, Hjalmar C., de Vries, Jan, Wessels, Frank J., Wilmink, J.W., Molenaar, I.Q., Besselink, Marc G., van Lienden, Krijn P.

Get full text

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis by Janssen, Quisette P, Buettner, Stefan, Suker, Mustafa, Beumer, Berend R, Addeo, Pietro, Bachellier, Philippe, Bahary, Nathan, Bekaii-Saab, Tanios, Bali, Maria A, Besselink, Marc G, Boone, Brian A, Chau, Ian, Clarke, Stephen, Dillhoff, Mary, El-Rayes, Bassel F, Frakes, Jessica M, Grose, Derek, Hosein, Peter J, Jamieson, Nigel B, Javed, Ammar A, Khan, Khurum, Kim, Kyu-Pyo, Kim, Song Cheol, Kim, Sunhee S, Ko, Andrew H, Lacy, Jill, Margonis, Georgios A, McCarter, Martin D, McKay, Colin J, Mellon, Eric A, Moorcraft, Sing Yu, Okada, Ken-Ichi, Paniccia, Alessandro, Parikh, Parag J, Peters, Niek A, Rabl, Hans, Samra, Jaswinder, Tinchon, Christoph, van Tienhoven, Geertjan, van Veldhuisen, Eran, Wang-Gillam, Andrea, Weiss, Matthew J, Wilmink, Johanna W, Yamaue, Hiroki, Homs, Marjolein Y V, van Eijck, Casper H J, Katz, Matthew H G, Groot Koerkamp, Bas

“…Abstract Background FOLFIRINOX is a standard treatment for metastatic pancreatic cancer patients. The effectiveness of neoadjuvant FOLFIRINOX in patients with…”
Get full text

Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study by Ruarus, Alette H, Vroomen, Laurien G P H, Geboers, Bart, van Veldhuisen, Eran, Puijk, Robbert S, Nieuwenhuizen, Sanne, Besselink, Marc G, Zonderhuis, Barbara M, Kazemier, Geert, de Gruijl, Tanja D, van Lienden, Krijn P, de Vries, Jan J J, Scheffer, Hester J, Meijerink, Martijn R

“…Background Patients with locally advanced pancreatic cancer have a dismal prognosis, with a median overall survival (OS) of 12-14 months with systemic…”
Get full text

Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma: A Prospective Pilot Study by Franken, Lotte C., van Veldhuisen, Eran, Ruarus, Alette H., Coelen, Robert J.S., Roos, Eva, van Delden, Otto M., Besselink, Marc G., Klümpen, Heinz-Josef, van Lienden, Krijn P., van Gulik, Thomas M., Meijerink, Martijn R., Erdmann, Joris I.

“…To investigate the safety and efficacy of percutaneous or open irreversible electroporation (IRE) in a prospective cohort of patients with locally advanced,…”
Get full text

Determination of vascular involvement and resectability in locally advanced and (borderline) resectable pancreatic cancer using intra-operative ultrasound – A prospective multicenter study by Michiels, Nynke, Doppenberg, Deesje, Groen, Jesse, Bonsing, Bert, Busch, Olivier, Crobach, Stijn, van Delden, Otto, van Dieren, Susan, Farina, Arantza, de Hingh, Ignace, Hurks, Rob, Nederend, Joost, Feshtali, Shirin Shahbazi, Tank, Yeliz, van Veldhuisen, Eran, Wasser, Martin, Besselink, Marc, Mieog, Sven

Get full text

Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study by van Eijck, Casper W F, Vadgama, Disha, van Eijck, Casper H J, Wilmink, Johanna W

“…Beyond demographic and immune factors, metabolic considerations, particularly metformin's recognized impact in oncology, warrant exploration in treating…”
Get full text

Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study by Michiels, Nynke, Doppenberg, Deesje, Groen, Jesse V., van Veldhuisen, Eran, Bonsing, Bert A., Busch, Olivier R., Crobach, A. Stijn L. P., van Delden, Otto M., van Dieren, Susan, Farina, Arantza, de Hingh, Ignace H. J. T., Hurks, Rob, Nederend, Joost, Shahbazi Feshtali, Shirin, Tank, Yeliz, Vahrmeijer, A. L., Wasser, Martin, Besselink, Marc G., Mieog, J. Sven D.

“…Background Determining the resectability of pancreatic cancer with vascular involvement on preoperative computed tomography imaging remains challenging,…”
Get full text

Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison by van Veldhuisen, Eran, Vroomen, Laurien G., Ruarus, Alette H., Derksen, Tyche C., Busch, Olivier R., de Jong, Marcus C., Kazemier, Geert, Puijk, Robbert S., Sorgedrager, Natasha S., Vogel, Jantien A., Scheffer, Hester J., van Lienden, Krijn P., Wilmink, Johanna W., Besselink, Marc G., Meijerink, Martijn R.

“…To compare survival after CT-guided percutaneous irreversible electroporation (IRE) and folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX)…”
Get full text

ASO Visual Abstract: Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC)—A Prospective Multicenter Study by Michiels, Nynke, Doppenberg, Deesje, Groen, Jesse V., van Veldhuisen, Eran, Bonsing, Bert A., Busch, Olivier R., Crobach, A. Stijn L. P., van Delden, Otto M., van Dieren, Susan, Farina, Arantza, de Hingh, Ignace H. J. T., Hurks, Rob, Nederend, Joost, Shahbazi Feshtali, Shirin, Tank, Yeliz, Vahrmeijer, Alexander L., Wasser, Martin, Besselink, Marc G., Mieog, J. Sven D.

Get full text

Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): prospective pilot study by Stoop, Thomas F., van Veldhuisen, Eran, van Rijssen, L. Bengt, Klaassen, Remy, Gurney-Champion, Oliver J., de Hingh, Ignace H., Busch, Olivier R., van Laarhoven, Hanneke W. M., van Lienden, Krijn P., Stoker, Jaap, Wilmink, Johanna W., Nio, C. Yung, Nederveen, Aart J., Engelbrecht, Marc R. W., Besselink, Marc G.

“…Background Restaging of locally advanced pancreatic cancer (LAPC) after induction chemotherapy using contrast-enhanced computed tomography (CE-CT) imaging is…”
Get full text

Readily available biomarkers predict poor survival in metastatic pancreatic cancer by Strijker, Marin, van Veldhuisen, Eran, van der Geest, Lydia G., Busch, Olivier R., Bijlsma, Maarten F., Haj Mohammad, Nadia, Homs, Marjolein Y., van Hooft, Jeanin E., Verheij, Joanne, de Vos-Geelen, Judith, Wilmink, Johanna W., Steyerberg, W. Ewout W., Besselink, Marc G., van Laarhoven, Hanneke W.

“…Identification of metastatic pancreatic cancer (mPC) patients with the worst prognosis could help to tailor therapy. We evaluated readily available biomarkers…”
Get full text